These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
960 related items for PubMed ID: 11022966
1. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current. Witchel HJ, Hancox JC. Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):753-66. PubMed ID: 11022966 [Abstract] [Full Text] [Related]
2. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children. Antzelevitch C. J Electrocardiol; 2001 Oct; 34 Suppl():177-81. PubMed ID: 11781953 [Abstract] [Full Text] [Related]
3. [Evaluation of pro-arrhythmic risk of drugs due to QT interval prolongation by the HERG expression system]. Chachin M, Kurachi Y. Nihon Yakurigaku Zasshi; 2002 Jun; 119(6):345-51. PubMed ID: 12089906 [Abstract] [Full Text] [Related]
4. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death. Vincent GM. Annu Rev Med; 1998 Jun; 49():263-74. PubMed ID: 9509262 [Abstract] [Full Text] [Related]
10. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Roy M, Dumaine R, Brown AM. Circulation; 1996 Aug 15; 94(4):817-23. PubMed ID: 8772706 [Abstract] [Full Text] [Related]
11. Modulation of HERG potassium channels by extracellular magnesium and quinidine. Po SS, Wang DW, Yang IC, Johnson JP, Nie L, Bennett PB. J Cardiovasc Pharmacol; 1999 Feb 15; 33(2):181-5. PubMed ID: 10028924 [Abstract] [Full Text] [Related]
12. Non-invasive testing of acquired long QT syndrome: evidence for multiple arrhythmogenic substrates. Chevalier P, Rodriguez C, Bontemps L, Miquel M, Kirkorian G, Rousson R, Potet F, Schott JJ, Baró I, Touboul P. Cardiovasc Res; 2001 May 15; 50(2):386-98. PubMed ID: 11334843 [Abstract] [Full Text] [Related]
13. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Sanguinetti MC, Jiang C, Curran ME, Keating MT. Cell; 1995 Apr 21; 81(2):299-307. PubMed ID: 7736582 [Abstract] [Full Text] [Related]
14. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications. Thomas D, Karle CA, Kiehn J. Curr Pharm Des; 2006 Apr 21; 12(18):2271-83. PubMed ID: 16787254 [Abstract] [Full Text] [Related]
15. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. Swan H, Viitasalo M, Piippo K, Laitinen P, Kontula K, Toivonen L. J Am Coll Cardiol; 1999 Sep 21; 34(3):823-9. PubMed ID: 10483966 [Abstract] [Full Text] [Related]